VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
ACH
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
ACHAccendra Health, Inc.
$0.20$16M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksACHQuarterly Financials

Accendra Health, Inc. (ACH) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Accendra Health, Inc. (ACH) quarterly income statement — complete revenue, gross profit & net income history

Income StatementBalance SheetCash FlowRatios

ACH Income Statement

Quarterly statement

ACH Income Statement

Accendra Health, Inc. (ACH) annual income statement — 30-year revenue, gross profit & net income history

AnnualQuarterly
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21
Sales/Revenue601.77M613.23M627.78M708.97M697.26M681.92M2.63B2.7B686.85M660.4M637.84M2.66B2.59B2.56B2.52B2.55B2.5B2.5B2.41B2.47B
Revenue Growth %-13.69%-10.07%-76.15%-73.7%1.52%3.26%-----74.72%4.12%3.78%2.53%4.82%3.4%-0.19%0.42%3.46%4.46%
Cost of Goods Sold0349.83M349.75M385.71M375.07M357.31M2.11B2.12B355.07M344.37M338.25M2.09B2.05B2.04B2.03B2.14B1.98B1.97B2.03B2.13B
COGS % of Revenue-57.05%55.71%54.4%53.79%52.4%80.02%78.5%51.7%52.15%53.03%78.54%79.22%79.74%80.29%84.04%79.45%78.7%84.48%86.16%
Gross Profit0263.41M278.03M323.26M322.2M324.6M526.01M579.77M331.77M316.03M299.59M569.92M538.5M519.43M497.31M407.12M513.28M532.5M373.45M341.57M
Gross Margin %-42.95%44.29%45.6%46.21%47.6%19.98%21.5%48.3%47.85%46.97%21.46%20.78%20.26%19.71%15.96%20.55%21.3%15.52%13.84%
Gross Profit Growth %-100%-18.85%-47.14%-44.24%-2.89%2.71%-----39.76%39.99%4.91%-2.46%33.17%19.19%56.09%33.1%-15.65%-14.29%
Operating Expenses249.46M298.56M255.23M271.5M265.84M267.85M525.89M841.73M300.69M299.11M292.62M509.9M514.66M508.59M487.5M460.6M453.03M457.42M312.39M279.55M
OpEx % of Revenue41.45%48.69%40.66%38.3%38.13%39.28%19.98%31.22%43.78%45.29%45.88%19.2%19.86%19.84%19.32%18.05%18.14%18.3%12.98%11.33%
Selling, General & Admin249.46M243.56M255.23M271.5M265.84M267.85M462.35M493.07M272.32M269.92M0457.23M452.58M455.03M448.72M455.86M430.96M421.93M269.47M266.4M
SG&A % of Revenue41.45%39.72%40.66%38.3%38.13%39.28%17.57%18.29%39.65%40.87%-17.21%17.46%17.75%17.79%17.87%17.26%16.88%11.2%10.8%
Research & Development0000000000013.2M00000000
R&D % of Revenue-----------0.5%--------
Other Operating Expenses01000K00001000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K
Operating Income1.33M-35.15M22.8M51.76M56.36M56.75M124K-261.97M31.08M16.92M6.97M60.02M23.84M10.84M9.81M-53.48M60.25M75.08M61.06M62.02M
Operating Margin %0.22%-5.73%3.63%7.3%8.08%8.32%0%-9.72%4.52%2.56%1.09%2.26%0.92%0.42%0.39%-2.1%2.41%3%2.54%2.51%
Operating Income Growth %-97.63%-161.94%18288.71%119.76%81.34%235.36%-----28.93%212.23%-60.43%-85.56%-83.94%-186.23%-4.18%-22.5%-58.38%-35.13%
EBITDA1.33M30.55M84.54M81.63M120.46M99.73M61.28M-196.78M92.69M80.8M81.06M130.76M97.49M82.9M80.73M19.75M118.4M148.25M85.18M74.2M
EBITDA Margin %0.22%4.98%13.47%11.51%17.28%14.63%2.33%-7.3%13.5%12.24%12.71%4.92%3.76%3.23%3.2%0.77%4.74%5.93%3.54%3.01%
EBITDA Growth %-98.89%-69.37%37.97%141.48%29.95%23.43%----0.41%562.07%-17.66%-44.08%-5.23%-73.38%38.45%24.07%-49.77%-32.09%
D&A (Non-Cash Add-back)065.7M61.74M29.87M64.1M42.99M61.15M65.19M61.61M63.88M74.09M70.74M73.65M72.06M70.93M73.23M58.15M73.16M24.13M12.18M
EBIT0-53.09M16.1M19.96M25.39M-58.94M-1.11M-263.95M29.91M16.11M15.09M87.67M27.14M9.77M8.42M-54.26M59.46M74.3M60.28M75.05M
Net Interest Income0-34.54M-32.35M-27.93M-29.03M-26.01M-33.96M-35.7M-36.55M-35.9M-35.66M-36.86M-38.13M-40.73M-42.2M-41.16M-39.87M-35.84M-12.02M-11.31M
Interest Income00000000000000000000
Interest Expense37.62M34.54M32.35M27.93M29.03M26.01M33.96M35.7M36.55M35.9M35.66M36.86M38.13M40.73M42.2M41.16M39.87M35.84M12.02M11.31M
Other Income/Expense-38.15M-52.48M-39.05M-59.73M-59.99M-141.7M-35.2M-37.68M-30.12M-26.4M-26.29M-39.02M-34.83M-41.8M-43.59M-41.95M-40.65M-36.62M-12.8M-12.11M
Pretax Income-36.82M-87.63M-16.25M-7.97M-3.63M-84.95M-35.07M-299.65M958K-9.48M-19.32M21M-10.98M-30.96M-33.78M-95.43M19.59M38.46M48.26M49.92M
Pretax Margin %-6.12%-14.29%-2.59%-1.12%-0.52%-12.46%-1.33%-11.11%0.14%-1.44%-3.03%0.79%-0.42%-1.21%-1.34%-3.74%0.78%1.54%2%2.02%
Income Tax-18.86M1.44M-9.78M1.47M1.97M-1.13M-10.09M-3.54M-303K-2.74M-5.93M3.21M-4.56M-2.72M-9.36M-37.44M7.1M9.86M8.98M7.94M
Effective Tax Rate %51.22%-1.65%60.19%-18.47%-54.25%1.33%28.77%1.18%-31.63%28.9%30.69%15.3%41.5%8.79%27.71%39.23%36.22%25.63%18.6%15.91%
Net Income-19.7M-89.07M-6.47M-56.33M-150.28M-869.06M-24.98M-296.12M-12.77M-31.91M-21.89M17.78M-6.43M-28.24M-24.42M-57.99M12.5M28.6M39.28M41.98M
Net Margin %-3.27%-14.52%-1.03%-7.94%-21.55%-127.44%-0.95%-10.98%-1.86%-4.83%-3.43%0.67%-0.25%-1.1%-0.97%-2.27%0.5%1.14%1.63%1.7%
Net Income Growth %86.89%89.75%74.11%80.98%-1076.79%-2623.21%----10.37%130.67%-151.42%-198.73%-162.17%-238.16%-71.68%-56.59%-43.56%-17.28%
Net Income (Continuing)0-89.07M-6.47M-9.44M-5.61M-83.82M-24.98M-296.12M1.26M-6.74M-13.39M17.78M-6.43M-28.24M-24.42M-57.99M12.5M28.6M39.28M41.98M
Discontinued Operations000-1000K-1000K-1000K00-1000K-1000K-1000K000000000
Minority Interest00000000000000000000
EPS (Diluted)0.00-1.16-0.08-0.73-1.94-11.30-0.32-3.84-0.17-0.42-0.290.23-0.08-0.37-0.32-0.770.160.370.520.55
EPS Growth %100%89.73%73.56%80.99%-1041.18%-2590.48%----9.38%129.87%-152.69%-200%-161.54%-240%-72.41%-57.47%-46.94%-23.61%
EPS (Basic)0.00-1.16-0.08-0.73-1.94-11.30-0.32-3.84-0.17-0.42-0.290.23-0.08-0.37-0.32-0.770.170.380.530.57
Diluted Shares Outstanding076.7M76.7M76.7M77.29M76.94M77.27M77.17M77.09M76.73M76.32M77.78M76.2M75.8M75.18M74.99M76.42M76.3M76.02M76M
Basic Shares Outstanding076.7M76.7M76.7M77.29M76.94M77.27M77.17M77.09M76.73M76.32M76.28M76.2M75.8M75.18M74.99M74.91M74.71M73.64M73.29M
Dividend Payout Ratio-------------------0.44%